23 May 2013
Keywords: pharmacia, licenses, tolterodine, kissei, pharmaceutical, signed, codevelopment
Article | 31 July 1995
Pharmacia and Kissei Pharmaceutical have signed a codevelopment agreement in Japan for tolterodine, Pharmacia's muscarinic receptor antagonist which is being ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.